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Tuesday, April 27, 2021 
 
 
During this COVID-19 pandemic and other future events, the Center for Disaster 
Medicine (CDM) at New York Medical College has been and will continue to be a 
source of reliable information, education and models for mitigation, preparedness, 
response and recovery. We hope this informational document helps in providing 
filtered and actionable information. As the pace of new information and changes 
occur, we will evaluate the current once per week to determine if this information 
should be provided on a more frequent basis.   
 
 
                                                                                                                        
David Markenson, M.D., M.B.A. 
Director 









Worldwide 147,918,659 3,122,200 85,628,214 Not Available 
United States 32,125,098 572,674 Not Available 427,217,093 
New Jersey 988,886 25,399 Not Available 13,373,810 
New York 2,034,102 52,042 Not Available 50,361,096 
Connecticut 336,933 8,066 Not Available 7,889,286 
 
Information as of 4/27/21 at 0600 EDT. Source: https://coronavirus.jhu.edu/map.html  
 







Center for Disaster Medicine Updates 
 
● On April 26, 2021, collaborated with National Medical Society of Spain and presented at 
National Medical Society Annual Conference regarding “The importance of increasing 
medical training for police officers in Spain during COVID-19.” 
● Presented lecture regarding COVID-19 response and best practices to graduate students 
enrolled in Master in Homeland Security degree in Guatemala. 
● Coordinating and overseeing COVID-19 screenings at NYMC campus. 
● Continue to partner with local organizations such as Westchester Department of Emergency 
Services and Westchester Medical Center to ensure ongoing collaboration with all public 
safety agencies. 
● Coordinating volunteers to support local public health response to COVID-19. 
● Conducting research and analysis of current events and COVID-19 response to identify 
strengths and areas for improvement in other regions. 
● Updating and developing new programs to provide enhanced education on public health 
emergencies including pandemics. 
● Exploring course development opportunities in infection prevention and control for frontline 
responders in the hospital and in the field. 
● Serving as a source of information for COVID-19 related concerns or questions regarding 
public health, emergency medical service (EMS), public safety and healthcare response.  
● Local networking and pandemic response analysis for New York’s tri-state area, using first-
person experiences to highlight current trends. 
 
To view the Center for Disaster Medicine's newest webinar, please click here - The 





● Following a thorough safety review, including two meetings of the CDC’s Advisory 
Committee on Immunization Practices, the U.S. Food and Drug Administration and the U.S. 
Centers for Disease Control and Prevention have determined that the recommended pause 
regarding the use of the Janssen (Johnson & Johnson) COVID-19 Vaccine in the U.S. 
should be lifted and use of the vaccine should resume. The pause was recommended after 
reports of six cases of a rare and severe type of blood clot in individuals following 
administration of the Janssen COVID-19 Vaccine. During the pause, medical and scientific 
teams at the FDA and CDC examined available data to assess the risk of thrombosis 
involving the cerebral venous sinuses, or CVST (large blood vessels in the brain) and other 
sites in the body (including but not limited to the large blood vessels of the abdomen and the 
veins of the legs) along with thrombocytopenia, or low blood platelet counts. The teams at 
FDA and CDC also conducted extensive outreach to providers and clinicians to ensure they 
were made aware of the potential for these adverse events and could properly manage and 
recognize these events due to the unique treatment required for these blood clots and low 
platelets, also known as thrombosis-thrombocytopenia syndrome (TTS). 
https://www.cdc.gov/media/releases/2021/fda-cdc-lift-vaccine-use.html  
 
The White House  
 
Press Briefing by White House COVID-19 Response Team and Public Health Officials: On April 
23, 2021, Dr. Walensky provided an update on the state of the pandemic, Dr. Fauci highlighted 









The official website of the White House delivers bold action and immediate relief for American 
families as the country grapples with converging crises. This includes actions to control the 
COVID-19 pandemic, provide economic relief, tackle climate change and advance racial equity 
and civil rights, as well as immediate actions to reform our immigration system and restore 




Health and Human Services (HHS) 
 
HHS Launches ‘We Can Do This: Live’ Initiative to Increase COVID-19 Vaccine Confidence- As 
part of the Biden-Harris Administration’s “We Can Do This” public education campaign to 
increase confidence in the COVID-19 vaccines and encourage vaccination, the Department of 
Health and Human Services (HHS) is launching a new initiative today to connect Americans with 
facts and information on vaccines from doctors, scientists and health professionals through high-








National Institutes of Health (NIH)  
 
COVID-19 vaccine responses to be studied in people with immune deficits- A study assessing 
how people with immune system deficiencies or dysregulations respond to COVID-19 
vaccination has begun enrolling participants at the National Institutes of Health Clinical Center in 
Bethesda, Maryland. The single-site study is led by researchers from the National Institute of 
Allergy and Infectious Diseases (NIAID) and aims to enroll 500 people, 400 with primary or 






United States Food and Drug Administration (FDA) 
 
As of April 23, 2021, 369 tests and sample collection devices are authorized by the FDA 
under emergency use authorizations (EUAs). These include 270 molecular tests and 
sample collection devices, 76 antibody and other immune response tests and 23 antigen 
tests. There are 49 molecular authorizations and one antibody authorization that can be 
used with home-collected samples. There is one molecular prescription at-home test, two 
antigen prescription at-home tests, four over-the-counter (OTC) at-home antigen tests, 
and two OTC molecular tests. The FDA has authorized 8 antigen tests and 2 molecular 
  
Clinical trial of therapeutics for severely ill hospitalized COVID-19 patients begins- A new Phase 
3 trial to test the safety and efficacy of therapeutics for COVID-19 has begun enrolling patients 
hospitalized with life-threatening cases of COVID-19, including those with acute respiratory 
failure. The trial is supported by two components of the National Institutes of Health, the National 
Institute of Allergy and Infectious Diseases (NIAID) and the National Heart, Lung and Blood 
Institute (NHLBI), and is part of the NIH Accelerating COVID-19 Treatment Interventions and 




Large NIH clinical trial will test polyclonal antibody therapeutic for COVID-19- A Phase 2/3 trial to 
evaluate a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called 
SAB-185, has begun enrolling non-hospitalized people with mild or moderate cases of COVID-
19. The trial, ACTIV-2, is sponsored by the National Institute of Allergy and Infectious Diseases 














FDA Continues Important Steps to Ensure Quality, Safety and Effectiveness of Authorized 
COVID-19 Vaccines- The U.S. Food and Drug Administration takes its responsibility to 
ensure medical product quality, safety and effectiveness very seriously. The American 
public puts its trust in the agency to ensure that all medical products, including COVID-19 








Centers for Disease Control and Prevention (CDC) 




On April 24, 2021, CDC provides updated Guidance for Operating Youth and Summer 
Camps During COVID-19- This guidance is intended for all types of youth day camps with 
additional guidance provided for overnight camps. Organizations that provide summer day 




CDC provides updated guidance regarding the possibility of getting COVID-19 even after 
vaccination - COVID-19 vaccines are effective. However, a small percentage of people 
who are fully vaccinated will still get COVID-19 if they are exposed to the virus that 
causes it. These are called “vaccine breakthrough cases.” This means that while people 
who have been vaccinated are much less likely to get sick, it may still happen. Experts 




CDC provides updated information about the variants in the United States- The emerging 
variants CDC is closely monitoring have mutations in the virus genome that alter the 
characteristics and cause the virus to act differently in ways that are significant to public 
health (e.g., causes more severe disease, spreads more easily between humans, 
requires different treatments, changes the effectiveness of current vaccines). It’s 
important to understand that genetic mutations are expected, and some variants can 
spread and become predominant while others subside. 
https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html  
 
CDC provides daily data tracker which has maps and charts tracking cases, deaths and 
trends of COVID-19 in the United States- updated daily by 8 pm ET. 
https://covid.cdc.gov/covid-data-tracker/#datatracker-home  
 




Center for Medicare and Medicaid Services (CMS)   






In this section, vaccine-related information from various sources will be collected, 
reviewed and tabulated here.  As of April 27, 2021, the FDA has granted Emergency Use 
Authorization (EUA) to Pfizer BioNTech, Moderna and Janssen/Johnson & Johnson. Now 
with three vaccines with EUA, the goal is to vaccinate a larger number of persons in the 
coming months throughout the United States. As additional vaccines are granted EUA, 
information for those vaccines will also be included. 
 
On April 23, 2021, CDC and FDA lift recommended pause on Johnson & Johnson 
(Janssen) COVID-19 Vaccine Use Following Thorough Safety Review- Following a 
thorough safety review, including two meetings of the CDC’s Advisory Committee on 
Immunization Practices, the U.S. Food and Drug Administration and the U.S. Centers for 
Disease Control and Prevention have determined that the recommended pause regarding 
the use of the Johnson & Johnson (Janssen) COVID-19 Vaccine in the U.S. should be 




CDC provides update on “How to talk about COVID-19 vaccines with friends and family”- 
COVID-19 vaccines are new, and it’s normal to for people to have questions about them. 
The sheer amount of information—and misinformation—about COVID-19 vaccines can be 
overwhelming to anyone.  
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/talk-about-vaccines.html  
 
CDC created this section regarding COVID-19 vaccinations in the United States- CDC 
provides overall US COVID-19 Vaccine, deliveries and administration, maps, charts and 
data updated daily by 8 PM. This section represents all vaccine partners including 
jurisdictional partner clinics, retail pharmacies, long-term care facilities, Federal 
Emergency Management Agency and Health Resources and Services Administration 
partner sites and federal entity facilities.  
https://covid.cdc.gov/covid-data-tracker/#vaccinations  
 
CDC created this section regarding the Johnson & Johnson’s Janssen vaccine to provide 
updated relevant information including side effects and safety data, clinical trials, 
demographic statistics and information on how the vaccine works. 
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html  
 
CDC created this section regarding the Moderna vaccine to provide updated relevant 
information including side effects and safety data, clinical trials demographic statistics and 
information on how the vaccine works. 
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html   
 
CDC created this section regarding the Pfizer BioNTech vaccine to provide updated 
relevant information including side effects and safety data, clinical trials demographic 




HHS created this section to provide the latest information about COVID-19 vaccines. 
https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html  
 
On April 26, 2021, Governor Cuomo updated New Yorkers on the state's vaccination 
program. 115,854 doses have been administered across the state's vast distribution 
network in the last 24 hours and more than 1.1 million doses have been administered 




The NYS DOH COVID-19 Vaccine Tracker Dashboard will update New Yorkers on the 
distribution of the vaccine including the number of doses received by the state, a 
breakdown of first or second doses and the number of persons vaccinated with the first 
and second doses in each region. 
https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker  
 
NYS DOH releases instructions for New York State-operated vaccination sites 
https://covid19vaccine.health.ny.gov/  
 
NYC DHMH provides 2021 Health Advisory #8 Administration of Johnson & Johnson/ 




For NYC DOHMH updated guidance regarding COVID-19 vaccine 
https://www1.nyc.gov/site/doh/covid/covid-19-vaccines.page  
 
The Vaccine Finder is a one-stop site for New Yorkers to find their nearest COVID-19 
vaccination location. The Vaccine Finder can also provide New Yorkers with information 




Educational Institution Information 
• Higher Education 
o When colleges switched to emergency remote instruction last year, some 
online learning advocates feared the hasty transition would leave 
students with a negative impression of online learning. While more pre-
pandemic online courses resulted from months of careful planning and 
significant financial investment, few instructors enjoyed these luxuries last 
spring. Despite the challenges and shortcomings of this emergency 
transition to remote instruction, a majority of students want the option to 
keep studying online, according to new survey results. The Digital 
Learning Pulse survey, published today, is the fourth in a series of 
surveys published by Bay View Analytics in partnership with Cengage, 
the Online Learning Consortium, the WICHE Cooperative for Educational 
Technologies and the University Professional and Continuing Education 
Association. https://www.insidehighered.com/news/2021/04/27/survey-
reveals-positive-outlook-online-instruction-post-pandemic  
o It was a trickle that became a deluge, as four-year colleges of all sorts 
began to announce their fall 2021 plans. Many took great pains to 
advertise a large share of in-person classes and activities, pushing as 
much as they could for a “return to normal.” Now that plan -- a return to 
majority in-person classes -- has become the norm among four-year 
institutions. But many community colleges have been planning for 
something different. Some have announced that classes will be largely 





o In a recent report, the department of Education details rules on how 
states can maintain K-12 funding under pandemic relief initiatives. For 






To view the latest information on clinical trials regarding COVID-19 
https://www.clinicaltrials.gov/ct2/results?recrs=&cond=Covid19&term=&cntry=&state=&cit
y=&dist=  










• Governor Andrew M. Cuomo announced that the Essential Workers Monument Advisory 
Committee met for the first time on Thursday, April 22. The Governor participated in the 
first meeting to discuss the design and other recommendations for a monument in New 
York City honoring the service and sacrifice of New York's essential workers throughout 
the COVID-19 pandemic. https://www.governor.ny.gov/news/governor-cuomo-
announces-first-meeting-essential-workers-monument-advisory-committee  
• Statement from Governor Cuomo on the resumption of the Johnson and Johnson 
vaccine: "World-renowned public health experts from the federal government and our 
own independent state task force have reviewed the data and reaffirmed that the use of 
the Johnson & Johnson vaccine can resume. The state of New York will resume 
administration of this vaccine at all of our state-run sites effective immediately. The 
vaccine is the weapon that will win the war against COVID and allow everyone to 
resume normalcy and we have three proven vaccines at our disposal. I urge every New 
Yorker to take whichever one is available to them first. The sooner we all get vaccinated, 




New York State Department of Health (DOH) 
 
On April 26, 2021, Governor Cuomo announced that spectator capacity at large-scale outdoor 
event venues, including professional and collegiate sports and live performing arts and 
entertainment, will increase from 20 to 33 percent beginning May 19. This increase will coincide 
with the previously announced increase in large-scale indoor event venue capacity. Social 









NYS DOH has created a dynamic COVID-19 Tracker which provides COVID-19 information 
regarding testing, cases, percentages and fatalities across New York State. It also breaks down 












• Governor Phil Murphy signed A5405, which will direct $10 million from the Coronavirus 
Relief Fund established under the Federal Coronavirus Aid, Relief and Economic 
Security (CARES) Act to the New Jersey Department of Agriculture. This funding will be 
distributed to seven New Jersey food banks in order to continue providing families with 
food assistance during the pandemic. Governor Murphy previously allocated $25 million 
in Coronavirus Relief Fund (CRF) funding to food banks in New Jersey. 
https://www.state.nj.us/governor/news/news/562021/approved/20210421b.shtml  
• Governor Murphy announced the easing of restrictions for a variety of activities and 
higher outdoor capacity limits, effective May 10. The changes, which include higher 
outdoor gathering limits, higher large venue outdoor capacities, higher maximum 
capacities for private catered events, and more, come as COVID-19 metrics are on the 




• Governor Ned Lamont announced that he is proposing to invest $103 million in funding 
that Connecticut is receiving from the American Rescue Plan Act to ensure that workers 
whose employment has been impacted by the COVID-19 pandemic have access to 
industry-aligned training programs that address the immediate hiring demands of 




• Governor Lamont provided legislative leaders and committees of cognizance with his 
proposal for use of the federal COVID-19 recovery funding that Connecticut is receiving 
from the American Rescue Plan Act. The proposal was developed pursuant to Special 
Act 21-1, which requires the governor to provide the Connecticut General Assembly with 
a plan for investing the funds. That law also requires the legislature’s Appropriations 
Committee to create its own proposal by May 16, and then the two plans will be subject 
to final negotiations between the legislature and the governor. 
https://portal.ct.gov/Office-of-the-Governor/News/Press-Releases/2021/04-
2021/Governor-Lamont-Releases-Proposal-for-American-Rescue-Plan-Act  
• Governor Lamont announced that beginning Tuesday, April 27, 2021, more than 50 
providers of COVID-19 vaccines in Connecticut will no longer require an appointment 
prior to providing individuals with vaccinations. Connecticut residents will be able walk-
up to the clinic and receive a vaccination on-the-spot. For the most up-to-date list of 






Local Updates  
 
New York Blood Center (NYBC) 
 
For the latest updated NYBC information about COVID-19: 
https://nybc.org/covid-19/  
 
New York City (NYC) Department of Health and Mental Hygiene (DOHMH)   
 
For NYC DOHMH updated COVID-19 data page 
https://www1.nyc.gov/site/doh/covid/covid-19-data.page  
 
For the latest COVID-19 information from NYC DOHMH 
https://www1.nyc.gov/site/doh/covid/covid-19-main.page  
 
Westchester County Department of Health 
 
For the latest breakdown of positive cases in Westchester County as of April 25, 2021 
https://wcgis.maps.arcgis.com/apps/dashboards/280339d96db14efd9cc304dba0f3a71d  
 
For the latest COVID-19 information in Westchester including how to avoid the latest vaccine scams 
offering earlier access to vaccines. 
https://health.westchestergov.com/2019-novel-coronavirus  
 
Putnam County Department of Health 
Breakdown of positive cases by towns in Putnam County as of April 23, 2021- 
https://www.putnamcountyny.com/covid19/    
 
For the latest COVID-19 information 
https://www.putnamcountyny.com/health/coronavirus/ 
 
Dutchess County Department of Health 
 
Breakdown of positive cases in Dutchess County as of April 26, 2021 
https://www.dutchessny.gov/Departments/DBCH/covid-19-dashboard.htm 
 
For the latest COVID-19 information: 
https://www.dutchessny.gov/Departments/DBCH/2019-Novel-Coronavirus.htm 
 
Orange County Department of Health 
 
Updated COVID-19 dashboard for Orange County, NY as of April 26, 2021 
https://ocnygis.maps.arcgis.com/apps/dashboards/21de1fb5ce0c480f95dc0cf2b8b83b71   
 




Rockland County Department of Health 
 
Review Rockland County’s dashboard with the latest COVID-19 information regarding cases as of 
April 26, 2021 
https://www.arcgis.com/apps/dashboards/d074e0336e81449393a76d1768ceb096  
 





CDC ACIP Recommends Lifting Pause of Johnson & Johnson Vaccine; Updated New York State 
HERDS Questions- GNYHA announces that the Centers for Disease Control and Prevention (CDC) 
Advisory Committee on Immunization Practices (ACIP) met today and voted to reaffirm that “Janssen 
[Johnson & Johnson] vaccine is recommended for persons 18 years of age and older in the U.S. 
population under the Food and Drug Administration’s Emergency Use Authorization.” Federal health 
officials will likely quickly take this recommendation and formally lift the pause on the use of single-
dose Johnson & Johnson COVID-19 vaccine. GNYHA will provide updates from Federal and State 




For the latest COVID-19 information for healthcare facilities from the Greater New York Hospital 




Center for Disaster Medicine Media 
 
New York Medical College Leadership News: 





Robert W. Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice 







Every effort is made to provide accurate and complete information in this newsletter. However, New 
York Medical College cannot guarantee that there will be no errors. NYMC makes no claims, promises or 
guarantees about the accuracy, completeness, or adequacy of the contents of the newsletters or the 
articles linked herein and further expressly disclaims liability for errors and omissions in the contents of 
this newsletter.  
 
This newsletter is for informational purposes only; it does not constitute medical advice. Always seek the 
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